Maynard Um
-
-
-
-
-
-
-
TD Cowen: 'Rhythm Pharmaceuticals (RYTM) is a top smid biotech pick'
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $152 at Citizens on 'Disappointing' Phase 3 EMANATE Trial
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $176 at Citizens on Imcivree Growth Potential
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $123 at H.C. Wainwright
-
-
-
-
-
-
-
Raymond James on Aardvark (AARD): 'we think ARD-101’s value proposition as potentially best-in-class
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Misses Q3 EPS by 11c, provides guidance
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
-
401,226 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

